In addition, Eli Lilly (LLY) advanced more than +9% after the drugmaker reported stronger-than-expected Q2 results and raised its full-year guidance. On the bearish side, McKesson (MCK) plunged over ...
The US stock markets opened lower on Friday, September 20, as investors held back after a jump in the previous session, which ...
Harvest ETFs Confirms Over $1 Billion in Total ETF Distributions Paid to Unitholders Since Inception
Harvest Portfolios Group Inc. ("Harvest") is pleased to announce that it has paid over C$1 billion in total ETF cash distributions since inception. Harvest ETFs is one of Canada's largest providers of ...
Shares of Novo Nordisk A/S fell after the Danish drugmaker reported mixed safety data on one of its next-generation ...
By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) -Novo Nordisk's shares fell nearly 5% on Friday after ...
He notes that the 2024 European Association for the Study of Diabetes (EASD) meeting revealed key data highlighting the importance of these weight-loss drugs, and he believes that players like Eli ...
He notes that the 2024 European Association for the Study of Diabetes (EASD) meeting revealed key data highlighting the importance of these weight-loss drugs, and he believes that players like Eli ...
While GE Healthcare now owns Mimneuro, the software works with PET tracers from multiple suppliers. GE Healthcare’s Vizamyl is supported, as are Lilly’s Amyvid and Life Molecular Imaging’s Neuraceq.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback